These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

371 related items for PubMed ID: 11734681

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Long-term efficacy and safety of botulinum toxin A injections to treat blepharospasm and hemifacial spasm.
    Ababneh OH, Cetinkaya A, Kulwin DR.
    Clin Exp Ophthalmol; 2014 Apr; 42(3):254-61. PubMed ID: 23844601
    [Abstract] [Full Text] [Related]

  • 3. [Essential blepharospasm and hemifacial spasm: characteristic of the patient, botulinum toxin A treatment and literature review].
    Schellini SA, Matai O, Igami TZ, Padovani CR, Padovani CP.
    Arq Bras Oftalmol; 2006 Apr; 69(1):23-6. PubMed ID: 16491229
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Efficacy of carbamazepine combined with botulinum toxin a in the treatment of blepharospasm and hemifacial spasm.
    Li XH, Lin SC, Hu YF, Liu LY, Liu JB, Hong YC.
    Eye Sci; 2012 Dec; 27(4):178-81. PubMed ID: 23225838
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The role of the injection botulinum toxin A in cases of blepharospasm syndrome, hemifacial spasm and Meige's syndrome.
    Bastola P, Chaudhary M, Agrawal JP, Shah DN.
    Kathmandu Univ Med J (KUMJ); 2010 Dec; 8(31):305-10. PubMed ID: 22610735
    [Abstract] [Full Text] [Related]

  • 11. Long-term efficacy of botulinum toxin A for treatment of blepharospasm, hemifacial spasm, and spastic entropion: a multicentre study using two drug-dose escalation indexes.
    Cillino S, Raimondi G, Guépratte N, Damiani S, Cillino M, Di Pace F, Casuccio A.
    Eye (Lond); 2010 Apr; 24(4):600-7. PubMed ID: 19648904
    [Abstract] [Full Text] [Related]

  • 12. [What to do in cases of inadequate effectiveness of botulinum toxin for the treatment of eyelid cramping?].
    Roggenkämper P.
    Ophthalmologe; 2007 Sep; 104(9):763-6. PubMed ID: 17726608
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Botulinum toxin type A influence on the lacrimal function of patients with facial dystonia].
    Oliveira FC, Oliveira GC, Cariello AJ, Felberg S, Osaki MH.
    Arq Bras Oftalmol; 2010 Sep; 73(5):405-8. PubMed ID: 21225122
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Long-term botulinum toxin treatment of benign essential blepharospasm, hemifacial spasm, and Meige syndrome.
    Czyz CN, Burns JA, Petrie TP, Watkins JR, Cahill KV, Foster JA.
    Am J Ophthalmol; 2013 Jul; 156(1):173-177.e2. PubMed ID: 23541393
    [Abstract] [Full Text] [Related]

  • 18. Effectivity of Dysport in patients with blepharospasm and hemifacial spasm who experienced failure with Botox.
    Badarny S, Susel Z, Honigman S.
    Isr Med Assoc J; 2008 Jul; 10(7):520-2. PubMed ID: 18751631
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.